SCHEMBL8488606

SCHEMBL8488606

c1cnc2ccc(Nc3ncnc4cnc(N5CCOCC5)nc34)cc2c1

nearest known ligand 0.52

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BRAF P15056 14/20 0.52
NTRK1 P04629 1/20 0.49
EGFR P00533 5/20 0.49
ERBB2 P04626 2/20 0.48
ERBB4 Q15303 1/20 0.48
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8485805 0.84 BRAF (0.50) BRAFNTRK1EGFRERBB2MAPT
SCHEMBL8487628 0.83 BRAF (0.55) BRAFNTRK1EGFR
SCHEMBL8316477 0.83 BRAF (0.64) BRAFEGFR
SCHEMBL8316098 0.82 ERBB2 (0.56) BRAFEGFRERBB2MAPT
SCHEMBL8487253 0.82 BRAF (0.53) BRAFNTRK1
SCHEMBL8320360 0.82 BRAF (0.56) BRAFEGFRERBB2MAPT
SCHEMBL8319713 0.82 EGFR (0.66) BRAFEGFRMAPT
SCHEMBL8489738 0.82 BRAF (0.54) BRAF
SCHEMBL8317331 0.82 BRAF (0.56) BRAFEGFRERBB2MAPT
SCHEMBL8315227 0.82 EGFR (0.66) BRAFEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977102-A INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; DR. KARL THOMAE GMBH (DE) 1999-11-02 US disclosed
EP-0885227-A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1997032882-A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed